The MarketReader Minute
π BioMarin Restructures, Biogen and AbbVie Decline, While BioNTech Surges Ahead with Promising Cancer Trials | Biotech Sector Insights
Gilead Sciences is set to present new data on its cancer treatment Trodelvy at the upcoming IASLC 2024 World Conference on Lung Cancer, focusing on various studies related to lung cancer, although the drug has not yet received regulatory approval for these indications.